These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 959602)

  • 1. Attentuation of precipitated abstinence in methadone-dependent rats by delta9-THC.
    Deikel SM; Carder B
    Psychopharmacol Commun; 1976; 2(1):61-5. PubMed ID: 959602
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.
    Hine B; Torrelio M; Gershon S
    Psychopharmacol Commun; 1975; 1(3):275-83. PubMed ID: 1241452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
    Frederickson RC; Hewes CR; Aiken JW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.
    Hine B; Torrelio M; Gershon S
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):185-8. PubMed ID: 1237925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of bone marrow leukopoiesis by delta9-tetrahydrocannabinol (delta9-THC).
    Johnson RJ; Wiersema V
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):613-6. PubMed ID: 4824832
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cannabis--clinical pharmacology].
    Retterstol N
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2125-6. PubMed ID: 4590073
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a delta9-tetrahydrocannabinol (delta9-THC) metabolite on bone marrow myelopoiesis.
    Johnson RJ; Wiersema V
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):393-6. PubMed ID: 4851725
    [No Abstract]   [Full Text] [Related]  

  • 8. Propofol sedation is reduced by delta9-tetrahydrocannabinol in mice.
    Brand PA; Paris A; Bein B; Meybohm P; Scholz J; Ohnesorge H; Tonner PH
    Anesth Analg; 2008 Jul; 107(1):102-6. PubMed ID: 18635473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and subchronic influences of tetrahydrocannabinols on water and food intake, body weight, and temperature in rats.
    Johansson JO; Jarbe TU; Henriksson BG
    TIT J Life Sci; 1975; 5(1-2):17-27. PubMed ID: 1188935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors.
    Reinhard C; Wolffgramm J
    Addict Biol; 2006 Jun; 11(2):131-44. PubMed ID: 16800826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
    Lemberger L; Martz R; Rodda B; Forney R; Rowe H
    J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug dependence and addiction from biochemical and pharmaceutical viewpoints].
    Herz A
    Internist (Berl); 1974 Jan; 15(1):40-6. PubMed ID: 4149640
    [No Abstract]   [Full Text] [Related]  

  • 13. Cannabis and its problems.
    Paton WD
    Proc R Soc Med; 1973 Jul; 66(7):718-21. PubMed ID: 4582312
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.
    Soria G; Castañé A; Berrendero F; Ledent C; Parmentier M; Maldonado R; Valverde O
    Eur J Neurosci; 2004 Oct; 20(8):2203-13. PubMed ID: 15450100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of delta9-THC on the catecholamine content of the guinea pig lung.
    Vachon L; Mathe AA; Weissman B
    Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):245-8. PubMed ID: 1257612
    [No Abstract]   [Full Text] [Related]  

  • 16. Substitution-detoxification and its role in the management of chronic benign pain.
    Halpern L
    J Clin Psychiatry; 1982 Aug; 43(8 Pt 2):10-4. PubMed ID: 6124535
    [No Abstract]   [Full Text] [Related]  

  • 17. Marijuana: a research overview.
    Rinaldi L
    Alaska Med; 1994; 36(2):107-13. PubMed ID: 7943621
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC).
    Sofia RD; Nalepa SD; Harakal JJ; Vassar HB
    J Pharmacol Exp Ther; 1973 Sep; 186(3):646-55. PubMed ID: 4728343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychodysleptic effects of cannabis].
    Carranza-Acevedo J
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():173-8. PubMed ID: 4447418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.